Domain 5 of high molecular weight kininogen inhibits collagen-mediated cancer cell adhesion and invasion in association with α-actinin-4

Biochemical and Biophysical Research Communications

Volumn 427, Issue 3, 2012, Pages 497-502

  Hatoh, Tsunetoshi ^a,b,c   Maeda, Toshinaga ^a   Takeuchi, Keisuke ^a   Ogikubo, Osamu ^b,d   Uchiyama, Susumu ^e   Otsuka, Takanobu ^b   Ohkubo, Iwao ^a,f   Ogita, Hisakazu ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c Chuno Kosei Hospital   (Japan)

^d Nagoya City Rehabilitation Hospital   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f TENSHI COLLEGE   (Japan)

Author keywords

Cancer cell; Cell adhesion; Cell invasion; High molecular weight kininogen; Plasma protein

Indexed keywords

ALPHA ACTININ 4; COLLAGEN; GLUTATHIONE TRANSFERASE; HIGH MOLECULAR WEIGHT KININOGEN; INTEGRIN; OCTAPEPTIDE; PEPTIDE;

ACTIN POLYMERIZATION; ARTICLE; CANCER CELL; CELL ADHESION; CELL INVASION; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CULTURE MEDIUM; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL;

ACTININ; AMINO ACID SEQUENCE; CELL ADHESION; CELL LINE, TUMOR; COLLAGEN; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASMS; PEPTIDE FRAGMENTS;

EID: 84867858633     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.079     Document Type: Article

References (21)

1. Parsons J.T., Horwitz A.R., Schwartz M.A. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat. Rev. Mol. Cell Biol. 2010, 11:633-643.
2. Rovensky Y.A. Cellular and molecular mechanisms of tumor invasion. Biochemistry (Moscow) 1998, 63:1029-1043.
3. Behrens J. The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Res. Treat. 1993, 24:175-184.
4. Kaplan A.P. Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI. Prog. Hemost. Thromb. 1978, 4:127-175.
5. Colman R.W., Schmaier A.H. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 1997, 90:3819-3843.
6. Asakura S., Hurley R.W., Skorstengaard K., Ohkubo I., Mosher D.F. Inhibition of cell adhesion by high molecular weight kininogen. J. Cell Biol. 1992, 116:465-476.
7. Chavakis T., Kanse S.M., Lupu F., Hammes H.P., Muller-Esterl W., Pixley R.A., Colman R.W., Preissner K.T. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. Blood 2000, 96:514-522.
8. Wachtfogel Y.T., DeLa Cadena R.A., Kunapuli S.P., Rick L., Miller M., Schultze R.L., Altieri D.C., Edgington T.S., Colman R.W. High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (Domain 3) and its light chain (domain 5). J. Biol. Chem. 1994, 269:19307-19312.
9. Guo Y.L., Wang S., Colman R.W. Kininostatin, an angiogenic inhibitor, inhibits proliferation and induces apoptosis of human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1427-1433.
10. Colman R.W., Jameson B.A., Lin Y., Johnson D., Mousa S.A. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Blood 2000, 95:543-550.
11. Zhang J.C., Claffey K., Sakthivel R., Darzynkiewicz Z., Shaw D.E., Leal J., Wang Y.C., Lu F.M., McCrae K.R. Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. FASEB J. 2000, 14:2589-2600.
12. Kawasaki M., Maeda T., Hanasawa K., Ohkubo I., Tani T. Effect of His-Gly-Lys motif derived from domain 5 of high molecular weight kininogen on suppression of cancer metastasis both in vitro and in vivo. J. Biol. Chem. 2003, 278:49301-49307.
13. Kamiyama F., Maeda T., Yamane T., Li Y.H., Ogukubo O., Otsuka T., Ueyama H., Takahashi S., Ohkubo I., Matsui N. Inhibition of vitronectin-mediated haptotaxis and haptoinvasion of MG-63 cells by domain 5 (D5(H)) of human high-molecular-weight kininogen and identification of a minimal amino acid sequence. Biochem. Biophys. Res. Commun. 2001, 288:975-980.
14. Johnson M.D., Torri J.A., Lippman M.E., Dickson R.B. The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res. 1993, 53:873-877.
15. Roberts S.B., Ripellino J.A., Ingalls K.M., Robakis N.K., Felsenstein K.M. Non-amyloidogenic cleavage of the beta-amyloid precursor protein by an integral membrane metalloendopeptidase. J. Biol. Chem. 1994, 269:3111-3116.
16. Fukumoto Y., Kurita S., Takai Y., Ogita H. Role of scaffold protein afadin dilute domain-interacting protein (ADIP) in platelet-derived growth factor-induced cell movement by activating Rac protein through Vav2 protein. J. Biol. Chem. 2011, 286:43537-43548.
17. An L.P., Maeda T., Sakaue T., Takeuchi K., Yamane T., Du P.G., Ohkubo I., Ogita H. Purification, molecular cloning and functional characterization of swine phosphatidylethanolamine-binding protein 4 from seminal plasma. Biochem. Biophys. Res. Commun. 2012, 423:690-696.
18. Otey C.A., Carpen O. Alpha-actinin revisited: a fresh look at an old player. Cell Motil. Cytoskeleton 2004, 58:104-111.
19. Preissner K.T., Reuning U. Vitronectin in vascular context: facets of a multitalented matricellular protein. Semin. Thromb. Hemost. 2011, 37:408-424.
20. van der Flier A., Sonnenberg A. Function and interactions of integrins. Cell Tissue Res. 2001, 305:285-298.
21. Humphries J.D., Byron A., Humphries M.J. Integrin ligands at a glance. J. Cell Sci. 2006, 119:3901-3903.